Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 16, 2026
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Community-Based Hereditary Breast and Ovarian Cancer Family History Assessment and Genetic Testing among Spanish-Speaking Hispanic/Latina Women in California.
Journal: Cancer research communications
Published: February 04, 2026
NCCN Guidelines® Insights: Breast Cancer, Version 5.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: November 10, 2025
Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.
Journal: JNCI cancer spectrum
Published: October 20, 2025
Assessing barriers to genomic testing in breast cancer among diverse patients: a qualitative community-engaged research study.
Journal: Breast cancer research and treatment
Published: July 07, 2025
Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 17, 2024
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 12, 2023
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 17, 2022
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: January 07, 2022
Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients.
Journal: ESMO open
Published: November 24, 2021
Last Updated: 09/26/2026